PathWhiz ID | Pathway | Meta Data |
---|---|---|
PW128327View Pathway |
drug action
Phentermine Norepinephrine Reuptake transporter Satiety Action PathwayHomo sapiens
Phentermine is an amine anorectic agent used in weight reduction in cases of exogenous obesity as an adjunct or alone. It is chemically related to amphetamine. It is thought that the primary way phentermine works is by inducing a reduction in appetite, potentially through the elevation of leptin levels. However, it's believed that there are likely additional mechanisms to help reduce the weight. This molecule also acts by releasing more noradrenaline from the presynaptic vesicles situated in the lateral hypothalamus. This elevation in this hormone's concentration within the synaptic cleft triggers the activation of beta2-adrenergic receptors. This drug also impacts dopamine levels, along with its consequential influence on serotonin. These combined effects lead to a continuous fight-or-flight response within the body, diminishing hunger signals. Phentermine inhibits the sodium-dependent noradrenaline transporter, the sodium-dependent serotonin transporter, and the sodium-dependent dopamine transporter. This drug is administered as an oral capsule.
|
Creator: Daphnee Created On: August 21, 2023 at 13:51 Last Updated: August 21, 2023 at 13:51 |
PW128346View Pathway |
drug action
Phentermine Serotonin Reuptake transporter Satiety Action PathwayHomo sapiens
Phentermine is an amine anorectic agent used in weight reduction in cases of exogenous obesity as an adjunct or alone. It is chemically related to amphetamine. It is thought that the primary way phentermine works is by inducing a reduction in appetite, potentially through the elevation of leptin levels. However, it's believed that there are likely additional mechanisms to help reduce the weight. This molecule also acts by releasing more noradrenaline from the presynaptic vesicles situated in the lateral hypothalamus. This elevation in this hormone's concentration within the synaptic cleft triggers the activation of beta2-adrenergic receptors. This drug also impacts dopamine levels, along with its consequential influence on serotonin. These combined effects lead to a continuous fight-or-flight response within the body, diminishing hunger signals. Phentermine inhibits the sodium-dependent noradrenaline transporter, the sodium-dependent serotonin transporter, and the sodium-dependent dopamine transporter. This drug is administered as an oral capsule.
|
Creator: Daphnee Created On: August 23, 2023 at 09:18 Last Updated: August 23, 2023 at 09:18 |
PW144804View Pathway |
drug action
Phentolamine Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 14:27 Last Updated: October 07, 2023 at 14:27 |
PW176116View Pathway |
Phentolamine Predicted Metabolism Pathway newHomo sapiens
Metabolites of Phentolamine are predicted with biotransformer.
|
Creator: Omolola Created On: November 29, 2023 at 14:05 Last Updated: November 29, 2023 at 14:05 |
PW145809View Pathway |
drug action
Phenyl aminosalicylate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 16:42 Last Updated: October 07, 2023 at 16:42 |
PW146213View Pathway |
drug action
Phenyl salicylate Drug Metabolism Action PathwayHomo sapiens
|
Creator: Ray Kruger Created On: October 07, 2023 at 17:41 Last Updated: October 07, 2023 at 17:41 |
PW250842View Pathway |
Phenylacetate degradationKlebsiella electrica
Phenylacetate degradation involves multiple enzymatic reactions that allow the bacterium to use phenylacetate as a carbon and energy source. Due to its hydrophobic nature, phenylacetate can enter bacterial cells via passive diffusion across the cell membrane. Once inside the cell, the enzyme phenylacetate-CoA ligase activates phenylacetate, converting it to phenylacetyl-CoA. This intermediate passes through several enzymatic processes, including oxidation, hydration, and cleavage, to produce metabolites like acetyl-CoA and succinyl-CoA, which then enter the citrate cycle for energy generation and biosynthesis.
|
Creator: Julia Wakoli Created On: May 21, 2024 at 18:14 Last Updated: May 21, 2024 at 18:14 |
PW088227View Pathway |
Phenylacetate MetabolismBos taurus
Phenylacetate (or phenylacetic acid) metabolism involves two steps. The first step is the conversion of phenylacetate into phenylacetyl-CoA which is catalyzed by acyl-coenzyme A synthetase ACSM1 or acyl-coenzyme A synthetase ACSM2B. Coenzyme A and ATP are also involved in this first step and AMP and pyrophosphate will be generated during the first step of metabolism. In the second step, phenylacetyl-CoA and L-glutamine interacts with glycine N-acyltransferase to generate coenzyme A as well as phenylacetylglutamine, of which the latter will be excreted in the urine. Phenylacetate metabolism provides a route that facilitates the excretion of nitrogen for patients with urea cycle defects; hence, it is important for clinical purposes.
|
Creator: Ana Marcu Created On: August 10, 2018 at 11:27 Last Updated: August 10, 2018 at 11:27 |
PW088323View Pathway |
Phenylacetate MetabolismRattus norvegicus
Phenylacetate (or phenylacetic acid) metabolism involves two steps. The first step is the conversion of phenylacetate into phenylacetyl-CoA which is catalyzed by acyl-coenzyme A synthetase ACSM1 or acyl-coenzyme A synthetase ACSM2B. Coenzyme A and ATP are also involved in this first step and AMP and pyrophosphate will be generated during the first step of metabolism. In the second step, phenylacetyl-CoA and L-glutamine interacts with glycine N-acyltransferase to generate coenzyme A as well as phenylacetylglutamine, of which the latter will be excreted in the urine. Phenylacetate metabolism provides a route that facilitates the excretion of nitrogen for patients with urea cycle defects; hence, it is important for clinical purposes.
|
Creator: Ana Marcu Created On: August 10, 2018 at 13:45 Last Updated: August 10, 2018 at 13:45 |
PW000033View Pathway |
Phenylacetate MetabolismHomo sapiens
Phenylacetate (or phenylacetic acid) metabolism involves two steps. The first step is the conversion of phenylacetate into phenylacetyl-CoA which is catalyzed by acyl-coenzyme A synthetase ACSM1 or acyl-coenzyme A synthetase ACSM2B. Coenzyme A and ATP are also involved in this first step and AMP and pyrophosphate will be generated during the first step of metabolism. In the second step, phenylacetyl-CoA and L-glutamine interacts with glycine N-acyltransferase to generate coenzyme A as well as phenylacetylglutamine, of which the latter will be excreted in the urine. Phenylacetate metabolism provides a route that facilitates the excretion of nitrogen for patients with urea cycle defects; hence, it is important for clinical purposes.
|
Creator: WishartLab Created On: August 01, 2013 at 13:54 Last Updated: August 01, 2013 at 13:54 |